ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,166.45
      -0.04%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. LENZ Therapeutics Inc (LENZ)

      7. LENZ Therapeutics Inc (LENZ) News

      LENZ

      LENZ Therapeutics (LENZ)

      LENZ Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LENZ
      DateTimeSourceHeadlineSymbolCompany
      06/10/20248:00AMGlobeNewswire Inc.LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024NASDAQ:LENZLENZ Therapeutics Inc
      05/30/20248:00AMGlobeNewswire Inc.LENZ Therapeutics to Present at the Jefferies Global Healthcare ConferenceNASDAQ:LENZLENZ Therapeutics Inc
      05/21/20248:31AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LENZLENZ Therapeutics Inc
      05/09/20244:18PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LENZLENZ Therapeutics Inc
      05/08/20245:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LENZLENZ Therapeutics Inc
      05/08/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LENZLENZ Therapeutics Inc
      05/08/20244:01PMGlobeNewswire Inc.LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:LENZLENZ Therapeutics Inc
      05/01/20244:01PMGlobeNewswire Inc.LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024NASDAQ:LENZLENZ Therapeutics Inc
      04/03/20247:00AMBusiness WireLENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
      04/02/20244:01PMBusiness WireLENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:LENZ

      Your Recent History

      BIT
      P204N6
      NLBNPIT204N6 20991231 26...
      Delayed Upgrade Clock